JPMorgan Chase & Co’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $747 | Hold |
98
| – | – | ﹤0.01% | 5766 |
|
|
2025
Q1 | $319 | Sell |
98
-47,966
| -100% | -$156K | ﹤0.01% | 5869 |
|
|
2024
Q4 | $216K | Sell |
48,064
-23,953
| -33% | -$108K | ﹤0.01% | 4501 |
|
|
2024
Q3 | $199K | Buy |
72,017
+28,690
| +66% | +$79.5K | ﹤0.01% | 4458 |
|
|
2024
Q2 | $148K | Sell |
43,327
-1,079,980
| -96% | -$3.69M | ﹤0.01% | 4417 |
|
|
2024
Q1 | $6.09M | Buy |
1,123,307
+1,119,766
| +31,623% | +$6.07M | ﹤0.01% | 2445 |
|
|
2023
Q4 | $19.2K | Hold |
3,541
| – | – | ﹤0.01% | 5252 |
|
|
2023
Q3 | $31.2K | Buy |
+3,541
| New | +$31.2K | ﹤0.01% | 5043 |
|